Further Information
KCNQ1, potassium voltage-gated channel, KQT-like subfamily, member 1, ATFB1, FLJ26167, JLNS1, KCNA8, KCNA9, KVLQT1, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS, Jervell and Lange-Nielsen syndrome 1, kidney and cardiac voltage dependend K+ channel, long (electrocardiographic) QT syndrome, Ward-Romano syndrome 1, slow delayed rectifier channel subunit
Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:Approx. 60kDa band observed in Human Heart lysates (calculated MW of 61.5kDa according to NP_861463.1). Recommended concentration: 1-3ug/ml.
An additional band of unknown identity was also consistently observed at 28kDa. This band was successfully blocked by incubation with the immunizing peptide.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Rat, Dog, Cow
The immunogen for this antibody is: C-EQLTVPRRGPDEGS
3784
potassium voltage-gated channel, KQT-like subfamily, member 1
KCNQ1
Homo sapiens
Liquid
NP_000209.2, NP_861463.1
32479527
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
This antibody is expected to recognize both reported isoforms (NP_000209.2; NP_861463.1).
P51787